中文 | English
Return
Total: 468 , 1/47
Show Home Prev Next End page: GO
Author:(Rui NA)

1.Epidemiological characteristics and influencing factors of atrial fibrillation in Suqian in 2019-2023

Rui SUN ; Na SUN ; RU WANG

Journal of Public Health and Preventive Medicine 2025;36(2):105-109

2.Exploring the practical ways and significance of narrative ability training for resident physicians

Lijia DU ; Rui ZHENG ; Jia NA ; Xiaoxiong ZHU ; Zhifen YANG

Chinese Medical Ethics 2025;38(6):695-703

3. Lycium barbarian seed oil activates Nrf2/ARE pathway to reduce oxidative damage in testis of subacute aging rats

Rui-Ying TIAN ; Wen-Xin MA ; Zi-Yu LIU ; Hui-Ming MA ; Sha-Sha XING ; Na HU ; Chang LIU ; Biao MA ; Jia-Yang LI ; Hu-Jun LIU ; Chang-Cai BAI ; Dong-Mei CHEN

Chinese Pharmacological Bulletin 2024;40(3):490-498

4.Expression Levels of Serum PTGS2 and CHI3L1 in Patients with Cerebrovascular Disease and Their Correlation with Cognitive Impairment

Na CAO ; Rui GU ; Xiaoling ZHAO ; Yan LIU

Journal of Modern Laboratory Medicine 2024;39(1):112-117

5.Construction of mouse intestinal organoid inflammation model

Hao CHEN ; Rui LI ; Fei YI ; Li ZHOU ; Jiaqi CHEN ; Fan ZHU ; Chengyan GUAN ; Na WU

Tianjin Medical Journal 2024;52(1):16-21

6.Clinical Characteristics of Adverse Events and Influencing Factors of Osteoking

Pengxuan DONG ; Rui QUAN ; Jun ZHOU ; Na LIN ; Baohong MI ; Weiheng CHEN

Chinese Journal of Experimental Traditional Medical Formulae 2024;30(18):132-138

7.Effects of scutellarin on endometrial carcinoma Ishikawa cells based on PI3K/Akt signaling pathway

Li-Li DAI ; Jing WANG ; Xu-Rui WEI ; Qing-Ya MA ; Na WANG ; Zhi-Xiang DU

The Chinese Journal of Clinical Pharmacology 2024;40(1):27-31

8.Study on therapeutic material basis and mechanism of Ganke Formula based on UPLC-Q-TOF/MS

Xue ZHANG ; Qaing-Hua YUAN ; Cheng-Shi HE ; Na XU ; Xiao-Rui CHEN ; Min ZHANG

The Chinese Journal of Clinical Pharmacology 2024;40(3):413-418

9.Research status on the mechanism of traditional Chinese medicine regulating TGF-β1/Smads signaling pathway to intervene liver fibrosis

Yong-Biao TAO ; Shi-Rui YANG ; Long-De WANG ; Ya-Na WU ; Zhi-Ming ZHANG ; Fu LI

The Chinese Journal of Clinical Pharmacology 2024;40(6):918-922

10.Clinical trial of semaglutide and saxagliptin combined with metformin in the treatment of patients with type 2 diabetes mellitus with abdominal obesity

Yong-Ju LIU ; Rui LI ; Na-Na HAO ; Wan-Wan LI

The Chinese Journal of Clinical Pharmacology 2024;40(10):1400-1404

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 468 , 1/47 Show Home Prev Next End page: GO